Cite
HARVARD Citation
Ang, D. et al. (2022). Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication. Alimentary pharmacology & therapeutics. 56 (3), pp. 436-449. [Online].